Orlando Standard

There were two companies in a city associated with Orange County, Florida, that received two FDA inspections in December 2023, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 33.3% decrease from the number of companies inspected in the previous month, when three companies were inspected through three inspections.

The companies inspected were involved in either the Drugs or Biologics sectors.

Both of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Company Name	Area of Business	Inspection Date	Result
Nexair, LLC	Drugs	12/06/2023	No Action Indicated (NAI)
Scendia Biologics, LLC	Biologics	12/19/2023	No Action Indicated (NAI)